3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
2
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Carcinoma, Non-Small-Cell Lung
3
Ovarian Neoplasms
2
Unresectable Stage III NSCLC
1
Squamous Cell Carcinoma of Head and Neck
1
Pharyngeal Neoplasms
1
Paranasal Sinus Neoplasms
1
Neoplasms, Unknown Primary
1
Laryngeal Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Carcinoma
1
Breast Neoplasms
1
Interventions
pembrolizumab
4
anlotinib
4
sintilimab
3
Paclitaxel
3
Leucovorin
3
Cetuximab
3
niraparib
2
Sorafenib
2
Radiotherapy
2
Nivolumab
2
Hyperthermic Intraperitoneal Chemotherapy
2
Gemcitabine
2
Fluorouracil
2
Drug Therapy
2
Docetaxel
2
Cisplatin
2
vistusertib
1
titanium silicide
1
tislelizumab
1
tirbanibulin
1
surufatinib
1
regorafenib
1
pemigatinib
1
olaparib
1
elemene
1
durvalumab
1
donafenib
1
daromun
1
avelumab
1
aumolertinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Carcinoma
×
CP protocol
×
Clear all
NCT00894569
2009-05-14
PACET-CUP
Heidelberg University
Phase 2
Unknown
150 enrolled